Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Detalles Bibliográficos
Autores principales: Zhao, Quanfeng, Ma, Pan, Fu, Peishu, Wang, Jiayu, Wang, Kejing, Chen, Lin, Yang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403888/
https://www.ncbi.nlm.nih.gov/pubmed/36034796
http://dx.doi.org/10.3389/fphar.2022.990048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403888/
https://www.ncbi.nlm.nih.gov/pubmed/36034796
http://dx.doi.org/10.3389/fphar.2022.990048

Ejemplares similares